# Aldeyra Therapeutics, Inc.: Form 8-K, filed Jul 15, 2026

- Company: [Aldeyra Therapeutics, Inc.](/companies/aldx.md) (CIK 1341235)
- Form: 8-K
- Filed: 2026-07-15
- Accepted by EDGAR: Jul 15, 2026, 16:46 ET
- Period: 2026-07-14
- Accession: 0001193125-26-304880
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1341235/000119312526304880/aldx-20260714.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1341235/000119312526304880/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1341235/000119312526304880/aldx-20260714.htm

Filed Jul 15, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-304880. Last ingested by Listed: Nov 14, 2026, 21:25 ET. No prices; not investment advice.